Welcome to our dedicated page for Cls Holdings Usa news (Ticker: CLSH), a resource for investors and traders seeking the latest updates and insights on Cls Holdings Usa stock.
CLS Holdings USA, Inc. reports developments tied to its diversified cannabis business operating as Cannabis Life Sciences. Company news centers on the City Trees brand, cannabis vape and concentrate products, the Oasis Cannabis Dispensary in Las Vegas, licensing-based market expansion, and partnerships involving solventless extraction technology and sustainable retail packaging.
Recurring updates also cover quarterly performance commentary, Nevada cannabis operations, out-of-state brand activity in New Mexico and New York, debt retirement, share repurchases, reverse stock split actions, and exchange-status matters. The company’s announcements commonly connect product development and dispensary activity with capital-structure and public-company governance decisions.
CLS Holdings USA reported a 41% increase in revenues, reaching $11,917,629 for fiscal year 2020, up from $8,459,048 in 2019.
The gross margin expanded to 50% from 43%, indicating a 16% improvement. Customer base increased by 70.48% to 228,458.
However, the company faced a net loss of $30,657,973, largely due to a $25,185,003 non-cash goodwill impairment. Adjusted EBITDA improved, totaling ($2,082,338), compared to ($22,882,678) in the prior year.
CLS Holdings USA (OTCQB:CLSH) reported record net revenues of $1,381,842 for July 2020, marking a 44.8% increase from July 2019 and 138% from July 2018. The company's gross margin stands at 52%. Key measures to ensure health safety amidst COVID-19 were implemented, such as employee testing and sanitization. CLS has seen a significant growth trajectory since acquiring its Nevada subsidiaries, with a tripling of monthly net revenue since July 2018.